| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.0M | -70.5% |
| Cost of Revenue | $5.8M | -53.8% |
| Gross Profit | $3.2M | -82.3% |
| R&D Expense | $180K | -75.4% |
| SG&A Expense | $6.0M | -30.0% |
| Operating Income | -$3.1M | -4919.5% |
| Interest Expense | $10K | -17.7% |
| Pre-tax Income | -$4.1M | +22.6% |
| Income Tax | $45K | +132.8% |
| Net Income | $5.8M | +491.1% |
| EPS (Basic) | $0.25 | +457.1% |
| EPS (Diluted) | $0.22 | +414.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -6.4% |
| Short-term Investments | $3.7M | -17.9% |
| Accounts Receivable | $708K | -63.7% |
| Current Assets | $8.4M | -10.6% |
| Total Assets | $13.1M | -6.5% |
| Current Liabilities | $5.3M | -28.2% |
| Long-term Debt | $499K | -69.8% |
| Total Liabilities |
| $5.8M |
| -45.0% |
| Stockholders' Equity | $8.8M | +88.7% |